An Analyst Sees 63% Upside for Trulieve Cannabis

As marijuana legalization gains momentum at the state level, multistate operator Trulieve Cannabis (OTC: TCNNF) continues to burnish its reputation with Wall Street analysts, who see the pot grower outperforming the market.

Joining the crowd looking for Trulieve to set the pace is Cowen Group (NASDAQ: COWN) analyst Vivien Azer, who just initiated coverage of the stock with an outperform rating and $65 price target.

That's 63% above where Trulieve closed trading on Thursday, though it's somewhat below the target some of her peers have set. Canaccord recently raised its target on the stock to 90 Canadian dollars (about $72 per share) while Stifel has a price of CA$118 ($94).

Source Fool.com